Group 1 - The core viewpoint of the news is the performance and financial details of Sanbo Brain Science Hospital Management Group Co., Ltd., which saw a stock price increase of 5.02% to 63.85 CNY per share, with a trading volume of 1.113 billion CNY and a turnover rate of 11.23%, resulting in a total market capitalization of 13.152 billion CNY [1] - Sanbo Brain's main business involves providing medical services, with revenue composition being 74.35% from medical services, 25.02% from pharmaceuticals, 0.39% from other supplementary services, and 0.24% from supply chain [1] - The company was established on November 25, 2003, and went public on May 5, 2023, indicating a relatively recent entry into the public market [1] Group 2 - Southern Fund's Southern CSI 1000 ETF (512100) is among the top ten circulating shareholders of Sanbo Brain, having increased its holdings by 249,800 shares in the second quarter, totaling 1.3295 million shares, which represents 0.83% of the circulating shares [2] - The Southern CSI 1000 ETF has a current scale of 64.953 billion CNY and has achieved a year-to-date return of 26.15%, ranking 1602 out of 4223 in its category, and a one-year return of 65.35%, ranking 1153 out of 3780 [2] - The fund manager, Cui Lei, has been in position for 6 years and 300 days, with the fund's total asset scale at 94.976 billion CNY, achieving a best return of 133.3% and a worst return of -18.12% during the tenure [3]
三博脑科股价涨5.02%,南方基金旗下1只基金位居十大流通股东,持有132.95万股浮盈赚取405.51万元